Efavirenz-13C6

Product Description
CAT No.
ALN-E003D04
CAS No.
1261394-62-0
Mol. F.
C813C6H9ClF3NO2
Mol. Wt.
321.6
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : (S)-6-Chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one-4a,5,6,7,8,8a-13C6
Smiles : FC(F)(F)[C@]([13C]1=[13CH][13C](Cl)=[13CH][13CH]=[13C]1NC2=O)(O2)C#CC3CC3
Inchi : InChI=1S/C23H32N2O4/c1-7-16-13-15(3)14-17(8-2)18(16)19-20(26)24-9-11-28-12-10-25(24)21(19)29-22(27)23(4,5)6/h13-14H,7-12H2,1-6H3
Technical Data
Reference
Development and validation of a HPLC analytical assay method for efavirenz tablets: a medicine for HIV infections
Osnir de Su00e1 Viana1 , Flu00e1via Patru00edcia Morais Medeiros2 , Severino Grangeiro-Ju00fanior2 , Miracy Muniz Albuquerque1 , Mu00f4nica Felts La Roca Soares1-3, Josu00e9 Lamartine Soares-Sobrinho1-3, Lariza Darlene Santos Alves1 , Larissa Arau00fajo Rolim1 , Keyla Emanuelle Ramos da Silva1 , Pedro Josu00e9 Rolim-NetonBraz. J. Pharm. Sci. vol.47 no.1 Su00e3o Paulo Jan./Mar. 2011
Investigation of the solvent-dependent photolysis of a nonnucleoside reverse-transcriptase inhibitor, antiviral agent efavirenz
Maryam A Jordaan and Michael Shapi – Antiviral Chemistry and Chemotherapy 2017: 1–11
Method Development and Validation for Related Impurities of Efavirenz by RP-HPLC Method
Desaraju Bhargavi, Bhukya Babu Rao, Gangarapu Kiran, Thumma Gouthami & Vasudha Bakshi – TACL 7 (5) 2017 pp 737 – 747
RFQ